Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT: Isosorbide Mononitrate and Butylphthalide in Acute Lacunar Stroke
NCT07252544Phase 3Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of isosorbide mononitrate, butylphthalide in lacunar infarction (LACI), sponsored by Beijing Tiantan Hospital. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
isosorbide mononitratebutylphthalide
03
Conditions
lacunar infarction (LACI)
Beyond the preview
Go deeper on NCT07252544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07252544.